Literature DB >> 6847274

The occurrence of carcinoma of the rectum following ileoproctostomy for familial polyposis.

A L Watne, J M Carrier, J P Durham, E E Hrabovsky, W Chang.   

Abstract

Ileoproctostomy was performed in 32 patients (13 Female and 19 male), with polyposis coli ranging in age from 10 to 54 years. Seven patients (22%) developed cancer of the retained rectum with a median follow-up of 14 years. Two (20%) of ten patients, followed for 10 to 15 years, and three (50%) of six patients, followed for 15 to 20 years, developed rectal cancer. Rectal cancer developed in two of 14 patients who had their ileoproctostomy at 14 cm and in five of 18 patients who had their ileoproctostomy at a higher level, with a median followup of 7 and 11 years, respectively. Rectal cancer developed in two of 15 teenage patients undergoing ileoproctostomy and in nine of 17 patients aged 20 to 54 years. The present average ages of the two groups were 25 and 41 years, and the average age at which rectal cancer appeared was 40 years. Three of the patients who developed rectal cancer had numerous polypectomies over the years, and there was a tendency to develop tubulovillous and villous adenomas with a variable degree of atypia leading to carcinoma. One patient also showed a return to high levels of coprostanol and secondary fecal bile acids. Proctocolectomy, if acceptable, may be the treatment of choice; ileoproctostomy may mean that the patient eventually will undergo a proctectomy. The ileoanal endorectal pull-through procedure has a great deal to offer to these patients, and further study is necessary to evaluate this procedure.

Entities:  

Mesh:

Year:  1983        PMID: 6847274      PMCID: PMC1353031          DOI: 10.1097/00000658-198305000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  Polyposis of the colon.

Authors:  F A COLLER; C T FLOTTE; F C O'DELL
Journal:  Ann Surg       Date:  1956-08       Impact factor: 12.969

2.  Subtotal colectomy with ileosigmoidostomy and fulguration of polyps in retained colon; evaluation as method of treatment of polyposis (adenomatosis) of colon.

Authors:  T C EVERSON; M J ALLEN
Journal:  AMA Arch Surg       Date:  1954-12

3.  The diagnosis and surgical treatment of patients with Gardner's syndrome.

Authors:  A L Watne; H Y Lai; J Carrier; W Coppula
Journal:  Surgery       Date:  1977-09       Impact factor: 3.982

4.  Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment.

Authors:  C G Moertel; J R Hill; M A Adson
Journal:  Arch Surg       Date:  1970-04

5.  Management of familial polyposis with preservation of the rectum.

Authors:  J C Harvey; S H Quan; M W Stearns
Journal:  Surgery       Date:  1978-10       Impact factor: 3.982

6.  Intestinal polyposis: the present position.

Authors:  H E Lockhart-Mummery
Journal:  Proc R Soc Med       Date:  1967-04

7.  Continent ileoanal endorectal pull-through.

Authors:  D W Shermeta; M A Helikson; J A Haller
Journal:  J Pediatr Surg       Date:  1981-04       Impact factor: 2.545

8.  Surgical management of familial polyposis and Gardner's syndrome.

Authors:  B S Gingold; D Jagelman; R B Turnbull
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

9.  Rectal cancer following colectomy for polyposis.

Authors:  M A Bess; M A Adson; L R Elveback; C G Moertel
Journal:  Arch Surg       Date:  1980-04
  9 in total
  3 in total

Review 1.  Overview of screening and management of familial adenomatous polyposis.

Authors:  M Rhodes; D M Bradburn
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

Review 2.  Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

Authors:  Alex Kartheuser; Pierre Stangherlin; Dimitri Brandt; Christophe Remue; Christine Sempoux
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

Authors:  G Winde; H G Gumbinger; H Osswald; F Kemper; H Bünte
Journal:  Int J Colorectal Dis       Date:  1993-03       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.